Clinical trial
A Clinical Investigation of the Cordis S.M.A.R.T. ™ CONTROL ™ Nitinol Stent System Versus the Bard® Luminexx™ 6F Vascular Stent for the Treatment of TASC C & D Superficial Femoral Artery Long Lesions
NCT00235131 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Investigation of the Cordis S.M.A.R.T. ™ CONTROL ™ Nitinol Stent System Versus the Bard® Luminexx™ 6F Vascular Stent for the Treatment of TASC C & D Superficial Femoral Artery Long Lesions
- Lead sponsor
- Cordis US Corp.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2005
- Completion date
- May 31, 2009
- Enrollment
- 200 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.